Deuterated JAK inhibitor and uses thereof

Disclosed is a JAK1 and/or JAK2 inhibitor of the following structural formula:or a pharmaceutically acceptable salt thereof. This invention also provides pharmaceutical compositions comprising a compound of Formula (I), optionally including additional therapeutic agents, and use in methods of treatment for hair loss disorders..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 05. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

SILVERMAN I ROBERT [VerfasserIn]
LIU CHANGHUA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-05, Last update posted on www.tib.eu: 2024-03-27, Last updated: 2024-03-29

Patentnummer:

US11919907

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001455850